<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "sarcopenia"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Inhibition of mTORC1 signaling in aged rats counteracts the decline in muscle mass and reverses multiple parameters of muscle signaling associated with sarcopenia</h4><p><a href="https://www.biorxiv.org/content/10.1101/591891v1">Link</a></p><p><b>Date:</b> 2019-03-28</p><p><b>Authors:</b> Giselle A. Joseph ... David J. Glass</p><p><b>Downloads:</b> 997</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> There is a lack of pharmacological interventions available for sarcopenia, a progressive age-associated loss of muscle mass, leading to a decline in mobility and quality of life.  We found mTORC1 (mammalian target of rapamycin complex 1), a well-established critical positive modulator of mass, to be hyperactivated in sarcopenic muscle.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32049447">Link</a></p><p><b>Date:</b> 02/12/2020</p><p><b>Authors:</b> Nicole Ebner ...  Stephan von Haehling</p><p><b>Journal:</b> J Cachexia Sarcopenia Muscle</p><p><b>IF (7 or above):</b> 9.55</p><p><b>Relevance Score:</b> 0.71</p></div><div class="everything-else-tail"><p><b>Abstract:</b> This article highlights preclinical and clinical studies in the field of wasting disorders that were presented at the 12th Cachexia Conference held in Berlin, Germany, in December 2019.  Herein, we summarize the biological and clinical significance of different strategies including antibodies that t ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Sarcopenia is an independent predictor of hospitalization in chronic kidney disease outpatients</h4><p><a href="https://www.biorxiv.org/content/10.1101/516096v1">Link</a></p><p><b>Date:</b> 2019-01-09</p><p><b>Authors:</b> Hye Yun Jeong ... So-Young Lee</p><p><b>Downloads:</b> 366</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background Patients with chronic kidney disease (CKD) experience much more marked and earlier muscle wasting than subjects who do not have chronic illnesses.  However, a few studies that have examined sarcopenia have been reported in CKD patients.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32071240">Link</a></p><p><b>Date:</b> 02/19/2020</p><p><b>Authors:</b> Joonho Suh ...  Yun-Sil Lee</p><p><b>Journal:</b> Proc. Natl. Acad. Sci. U.S.A.</p><p><b>IF (7 or above):</b> 9.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Growth and differentiation factor 11 (GDF11) and myostatin (MSTN) are closely related transforming growth factor β (TGF-β) family members, but their biological functions are quite distinct.  While MSTN has been widely shown to inhibit muscle growth, GDF11 regulates skeletal patterning and organ deve ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Physical activity improves sarcopenia in a murine model by enhancing the proliferative potential of muscle stem cells, oxidative capacity of mitochondrial enzymes and expression of Sestrins</h4><p><a href="https://www.biorxiv.org/content/10.1101/811638v1">Link</a></p><p><b>Date:</b> 2019-10-21</p><p><b>Authors:</b> Masroor Anwar ... A.B. Dey</p><p><b>Downloads:</b> 151</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Sarcopenia is a major health issue in old age.  Underlying molecular mechanisms in its genesis remain unclear and optimal animal models are yet to be established.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Predicting the risk of sarcopenia in elderly patients with patellar fracture: Development and assessment of a new predictive nomogram</h4><p><a href="https://www.biorxiv.org/content/10.1101/702548v1">Link</a></p><p><b>Date:</b> 2019-07-14</p><p><b>Authors:</b> Chen Yisheng ... Tao Jie</p><p><b>Downloads:</b> 141</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Purpose: This study was aimed at developing a risk prediction model for postoperative dysplasia in elderly patients with patellar fractures in China.  Patients and methods: We conducted a community survey of patients aged ≥55 years who underwent surgery for patellar fractures between January 2013 and October 2018, through telephone interviews, community visits, and outpatient followup.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Resveratrol attenuates high-fat diet-induced obesity and the aging-related sarcopenia mitochondrial dysfunction in skeletal muscle.</h4><p><a href="https://www.biorxiv.org/content/10.1101/823088v1">Link</a></p><p><b>Date:</b> 2019-10-30</p><p><b>Authors:</b> Chyi-Huey Bai ... Jia-Ping Wu</p><p><b>Downloads:</b> 126</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Sarcopenic obesity is a progressive loss of skeletal muscle mass and strength with increases in adiposity.  This study's aim was to investigate the effects of resveratrol on obesity or sarcopenia on potential therapy risk for skeletal muscle declines in physical function.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Clinical correlates of sarcopenia and falls in Parkinson's disease</h4><p><a href="https://www.biorxiv.org/content/10.1101/2019.12.17.879668v1">Link</a></p><p><b>Date:</b> 2019-12-17</p><p><b>Authors:</b> Danielle Pessoa Lima ... Pedro Braga-Neto</p><p><b>Downloads:</b> 123</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Sarcopenia is a complex and multifactorial geriatric condition seen in several chronic degenerative diseases.  This study aimed to screen for sarcopenia and fall risk in a sample of Parkinson's disease (PD) patients and to investigate demographic and clinical factors associated.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: AKT2 deficiency causes sarcopenia and metabolic disorder of skeletal muscle</h4><p><a href="https://www.biorxiv.org/content/10.1101/805812v1">Link</a></p><p><b>Date:</b> 2019-10-16</p><p><b>Authors:</b> Miao Chen ... Junmei Ye</p><p><b>Downloads:</b> 91</p><p><b>Relevance Score:</b> 0.71</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Skeletal muscle is responsible for the majority of glucose disposal in the body.  Insulin resistance in the skeletal muscle accounts for 85-90% of the impairment of total body glucose disposal in patients with tye 2 diabetes (T2D).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Neuronal Inhibition Of The Autophagy Nucleation Complex Extends Lifespan In Post-Reproductive C. elegans</h4><p><a href="https://www.biorxiv.org/content/10.1101/135178v1">Link</a></p><p><b>Date:</b> 2017-05-08</p><p><b>Authors:</b> Thomas Wilhelm ... Holger Richly</p><p><b>Downloads:</b> 1976</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Autophagy is a ubiquitous catabolic process, which causes cellular bulk degradation of cytoplasmic components and thereby regulates cellular homeostasis.  Inactivation of autophagy has been linked with detrimental effects to cells and organisms.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice</h4><p><a href="https://www.biorxiv.org/content/10.1101/779157v1">Link</a></p><p><b>Date:</b> 2019-10-04</p><p><b>Authors:</b> Azar Asadi Shahmirzadi ... Gordon J. Lithgow</p><p><b>Downloads:</b> 981</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The decline in early life mortality since the 1950s has resulted in dramatic demographic shift towards aged population.  Aging manifests as a decline in health, multiple organ dysfunction and increased vulnerability to diseases, which degrades quality of life.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Physical activity unveils the relationship between mitochondrial energetics, muscle quality and physical function in older adults</h4><p><a href="https://www.biorxiv.org/content/10.1101/164160v1">Link</a></p><p><b>Date:</b> 2017-07-15</p><p><b>Authors:</b> Giovanna Distefano ... Paul M. Coen</p><p><b>Downloads:</b> 489</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: The concept of mitochondrial dysfunction in aging muscle is highly controversial.  In addition, emerging evidence suggests that reduced muscle oxidative capacity and efficiency underlie the etiology of mobility loss in older adults.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Clonal expansion of mitochondrial DNA deletions is a private mechanism of ageing in long-lived animals</h4><p><a href="https://www.biorxiv.org/content/10.1101/273326v2">Link</a></p><p><b>Date:</b> 2018-02-28</p><p><b>Authors:</b> Lakshmi Narayanan Lakshmanan ... Jan Gruber</p><p><b>Downloads:</b> 422</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Disruption of mitochondrial metabolism and loss of mitochondrial DNA (mtDNA) integrity are widely considered as evolutionarily conserved (public) mechanisms of ageing (Lopez-Otin et al.  2013).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Age-associated different transcriptome profiling in zebrafish and rat: insight into diversity of vertebrate aging</h4><p><a href="https://www.biorxiv.org/content/10.1101/478438v1">Link</a></p><p><b>Date:</b> 2018-11-27</p><p><b>Authors:</b> Yusuke Kijima ... Shigeharu Kinoshita</p><p><b>Downloads:</b> 380</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Aging and death are inevitable for most species and are of intense interest for human beings.  Most mammals, including humans, show obvious aging phenotypes, for example, loss of tissue plasticity and sarcopenia.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Depletion of resident muscle stem cells inhibits muscle fiber hypertrophy induced by lifelong physical activity</h4><p><a href="https://www.biorxiv.org/content/10.1101/588731v1">Link</a></p><p><b>Date:</b> 2019-03-26</p><p><b>Authors:</b> Davis A. Englund ... Charlotte A. Peterson</p><p><b>Downloads:</b> 323</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: A reduction in skeletal muscle stem cell (satellite cell) content with advancing age is thought to directly contribute to the progressive loss of skeletal muscle mass and function with aging (sarcopenia).  However, we reported that the depletion of satellite cells throughout adulthood did not affect the onset or degree of sarcopenia observed in sedentary old mice.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Metabolite profile and mitochondrial energetics characterize poor early recovery of muscle mass following hind limb unloading in old mice</h4><p><a href="https://www.biorxiv.org/content/10.1101/183244v1">Link</a></p><p><b>Date:</b> 2017-08-31</p><p><b>Authors:</b> Xiaolei Zhang ... Paul M. Coen</p><p><b>Downloads:</b> 301</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The progression of age-related sarcopenia can be accelerated by impaired recovery of muscle mass following periods of disuse due to illness or immobilization.  The molecular underpinnings of poor recovery of aging muscle following disuse remain largely unknown.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Elevated serum aspartate aminotransferase levels concomitant with normal alanine aminotransferase levels in older low body weight people: Preliminary findings from a community-based epidemiological study</h4><p><a href="https://www.biorxiv.org/content/10.1101/528034v2">Link</a></p><p><b>Date:</b> 2019-01-26</p><p><b>Authors:</b> Michi Shibata ... Kei Nakajima</p><p><b>Downloads:</b> 197</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background Serum enzyme levels, including hepatic transaminase, are unknown in older people with low body weight (LBW), who can easily experience sarcopenia.  Therefore, we addressed preliminarily this issue in a cross-sectional study of an apparently healthy population.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Shared regulatory pathways reveal novel genetic correlations between grip strength and neuromuscular disorders</h4><p><a href="https://www.biorxiv.org/content/10.1101/765495v1">Link</a></p><p><b>Date:</b> 2019-09-13</p><p><b>Authors:</b> Sreemol Gokuladhas ... Justin O’Sullivan</p><p><b>Downloads:</b> 196</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Muscle weakness and muscle wasting can be a consequence of aging (sarcopenia) and neuromuscular disorders (NMD).  Genome-wide association (GWA) studies have identified genetic variants associated with grip strength (GS, an inverse measure of muscle weakness) and NMD (multiple sclerosis (MS), myasthenia gravis (MG) and amyotrophic lateral sclerosis (ALS)).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Cytosolic Proteostatic Adaptation to Mitochondrial Stress Causes Progressive Muscle Wasting</h4><p><a href="https://www.biorxiv.org/content/10.1101/733097v1">Link</a></p><p><b>Date:</b> 2019-08-12</p><p><b>Authors:</b> Xiaowen Wang ... Xin Jie Chen</p><p><b>Downloads:</b> 184</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Muscle wasting (or atrophy), defined by reduced myofiber size and muscle strength, occurs in primary neuromuscular diseases and during aging.  The progressive loss of muscle mass with aging is known as sarcopenia, and affects 35.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The RNA binding protein hnRNP-U is required for physiological hypertrophy of skeletal muscle</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.13.944298v1">Link</a></p><p><b>Date:</b> 2020-02-14</p><p><b>Authors:</b> Debalina Bagchi ... Ronald L Neppl</p><p><b>Downloads:</b> 70</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Skeletal muscle has the remarkable ability to modulate its mass in response to physiological changes associated with nutritional input, functional utilization, systemic disease, and age.  A decreased responsiveness to anabolic stimuli is thought to contribute significantly to the loss of skeletal muscle mass and strength associated with sarcopenia, however the molecular mechanisms precipitating this are unclear.</p></div></td></div><td></td></tr></table></div><hr></div></body></html>